Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000825715 | SCV000967164 | likely benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | p.Leu643Leu in Exon 11 of CBL: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue, is not located within the splice consensus sequence. It has been identified in 1/3738 African America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs139939244). |
Labcorp Genetics |
RCV001505302 | SCV001710194 | likely benign | RASopathy | 2024-10-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002497197 | SCV002799074 | likely benign | Juvenile myelomonocytic leukemia; CBL-related disorder | 2021-07-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004601207 | SCV005098185 | likely benign | Cardiovascular phenotype | 2024-04-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |